| Application no. and date | 06749324.7 (espacenet) (Federated) (European Patent Register), 20060405 | | Patent/reg. no. and date | DK/EP 1868635, 20170517 | | Publication date | 20071226 | | Priority no. and date | US 668774 P, 20050406 | | EP pub. no. and date |
EP 1868635 20071226 | | Effective date | | | Applicant/owner | Bristol-Myers Squibb Company, Route 206 and Province Line Road
Princeton, NJ 08543, US | | Applicant ref. no. | V140967 | | Inventor | Hagerty, David, 215 Avenue De Monaco
Cardiff by the Sea, CA 92007, US,
RUSNAK, James, 640 Pineville Road
Newtown, PA 18940, US | | Representative | Marks & Clerk LLP, 44 rue de la Vallée
BP 1775
L-1017 Luxembourg, LU | | Opponent | | | IPC Class | A61K 31/436 (2006.01) , A61K 31/5377 (2006.01) , A61K 31/573 (2006.01) , A61K 38/17 (2006.01) , A61K 39/395 (2006.01) , A61K 9/00 (2006.01) | | Title | FREMGANGSMÅDER TIL BEHANDLING AF IMMUNFORSTYRRELSER I FORBINDELSE MED
ORGANTRANSPLANTATION MED OPLØSELIGE, MUTERENDE CTLA4-MOLEKYLER | | Int. application no. | US2006012648 | | Int. publication no. | WO2006108035 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
